首页|期刊导航|中医药信息|清补通络方改善2型糖尿病小鼠认知障碍的机制研究

清补通络方改善2型糖尿病小鼠认知障碍的机制研究OA

Study on Mechanism of Qingbu Tongluo Formula in Improving Cognitive Impairment in Type 2 Diabetic Mice

中文摘要英文摘要

目的 观察清补通络方对2型糖尿病小鼠认知障碍的改善作用,探讨其减少Aβ沉积的作用机制.方法 70只C57BL/6J小鼠随机分为空白组(NC组)10只和造模组60只,造模组小鼠禁食过夜后连续3 d腹腔注射STZ 50 mg/kg建立2型糖尿病模型,选取造模成功小鼠50只继续进行高脂饲养,建立认知损伤模型.将造模成功的50只小鼠随机分为模型组(MG组),清补通络方低剂量组(Q-L组),清补通络方中剂量组(Q-M组),清补通络方高剂量组(Q-H组)和盐酸多奈哌齐组(DN组),每组10只.造模并分组成功后,NC组给予普通饲料,生理盐水灌胃;MG组持续给予高脂饲料并给予生理盐水灌胃;Q-L、Q-M、Q-M组分别给予清补通络方15.66、31.32、62.64 g/kg灌胃;DN组给予盐酸多奈哌齐0.65 mg/kg灌胃.均每日1次,连续干预8周.运用表面等离子共振生物分子相互作用分析系统(BiacoreT200)分析清补通络方与转化生长因子-β1(TGF-β1)结合力.干预8周后进行Morris水迷宫测试,RT-qPCR法检测脑组织TGF-β1 mRNA,HE染色观察脑组织病理变化,ELISA法检测小鼠血清及脑组织Aβ1-40 和Aβ1-42 含量,免疫组化观察海马组织TGF-β1、IDE和Aβ蛋白的表达.结果 Biacore结果显示清补通络方与TGF-β1有较强结合力;与模型组比较,各药物干预组小鼠逃避潜伏期缩短,穿越平台次数及目标象限停留时间均减少,脑组织细胞形态更完整,TGF-β1 mRNA表达减少,Aβ1-42、Aβ1-40含量显著降低,TGF-β1和Aβ表达下降,IDE表达上调(P<0.05).结论 清补通络方能够通过调控TGF-β1表达以减少Aβ沉积,从而发挥改善2型糖尿病小鼠认知障碍的作用.

Objective To investigate the improving effect of the Qingbu Tongluo Formula on cognitive impairment in type 2 diabetic mice and to explore its mechanism of action in reducing amyloid-beta(Aβ)deposition.Methods Seventy C57BL/6J were randomly divided into a normal control group(NC,n=10)and a modeling group(n=60).Mice in the model group were fasted overnight and then injected with STZ(50 mg/kg)intraperitoneally for 3 consecutive days to establish a type 2 diabetes model.Fifty successfully modeled mice were selected to maintain on the high-fat diet and then were subjected to induce cognitive impairment.After the successful modeling,fifty mice were divided into the following five groups:model group(MG),low-dose Qingbu Tongluo Formula group(Q-L group),medium-dose Qingbu Tongluo Formula group(Q-M group),high-dose Qingbu Tongluo Formula group(Q-H group),and donepezil hydrochloride group(DN group),with 10 mice in each group.NC group received standard chow and was gavaged with normal saline;MG group received high fat diet and was gavaged with normal saline;Q-L,Q-M,and Q-M groups were gavaged with Qingbu Tongluo Formula at doses of 15.66,31.32,and 62.64 g/kg respectively;DN group was gavaged with donepezil hydrochloride at dose of 0.65 mg/kg.All administrations were performed once daily and continued for 8 consecutive weeks.The binding affinity between Qingbu Tongluo Formula and transforming growth factor-beta 1(TGF-β1)was analyzed using a surface plasmon resonance(SPR)-based biomolecular interaction analysis system(Biacore T200).After 8 weeks of intervention,the Morris water maze test was conducted.The mRNA expression level of TGF-β1 in brain tissue was detected via RT-qPCR.Pathological changes in the brain tissue were observed through HE staining.The levels of Aβ1-40 and Aβ1-42 in serum and brain tissue were measured by ELISA.The expression of TGF-β1,IDE,and Aβ protein in the hippocampal tissue were examined using immunohistochemistry.Results Biacore analysis demonstrated a strong binding affinity between the Qingbu Tongluo Formula and TGF-β1.Compared with the model group,mice in the drug intervention groups exhibited shortened escape latency,a decreased number of platform crossings,and reduced time spent in the target quadrant.The morphology of brain tissue was found to be more intact.TGF-β1 mRNA expression was reduced,levels of Aβ1-42 and Aβ1-40 were significantly decreased,protein expression of TGF-β1 and Aβ was downregulated,and IDE expression was upregulated(P<0.05).Conclusion The Qingbu Tongluo Formula can improve cognitive impairment in type 2 diabetic mice by regulating TGF-β1 expression,which leads to reduced Aβ deposition.

李梓希;王一贝;孙彤;蔡萧君

黑龙江省中医药科学院,黑龙江 哈尔滨 150036黑龙江省中医药科学院,黑龙江 哈尔滨 150036黑龙江省中医药科学院,黑龙江 哈尔滨 150036黑龙江省中医药科学院,黑龙江 哈尔滨 150036

2型糖尿病认知障碍清补通络方转化生长因子-1胰岛素降解酶β-淀粉样蛋白

Type 2 diabetes-associated cognitive impairmentQingbu Tongluo FormulaTransforming growth factor-β1Insulin-degrading enzymeβ-amyloid

《中医药信息》 2026 (4)

44-51,8

黑龙江省中医药科研项目(ZHY2025-005)

10.19656/j.cnki.1002-2406.20260407

评论